A5063688361- Glioma Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Microtubule and mitosis dynamics
- Skin Protection and Aging
- Molecular Biology Techniques and Applications
- Immunotherapy and Immune Responses
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Dermatologic Treatments and Research
- Cancer Cells and Metastasis
- Dyeing and Modifying Textile Fibers
- Chromium effects and bioremediation
- Prostate Cancer Treatment and Research
- Methane Hydrates and Related Phenomena
- Endometrial and Cervical Cancer Treatments
- Brain Metastases and Treatment
- Cancer, Hypoxia, and Metabolism
Ain Shams University
2013-2023
Glioblastoma is the most aggressive primary malignant brain tumor in adults and characterized by poor prognosis. Immune evasion occurs via programmed death-ligand 1 (PD-L1)/programmed death receptor (PD-1) interaction. Some tumors have responded to PD-L1/PD-1 blockade treatment strategies, PD-L1 has been described as a potential predictive biomarker. This study discussed expression of CD8 glioblastomas.Thirty cases glioblastoma were stained immunohistochemically for CD8, where tissue above...
Summary Background Natural ultraviolet exposure induces hair damage, which is difficult to avoid. Most of the research work focused on effect epidermis, dermis as well immune system, whereas long‐term has not been investigated. Aim: we performed our experiment find out changes induced in follicle and shaft those patients exposed high doses (A B) during treatment other skin conditions. Patients Methods Light transmission electron microscopy examination scalp follicles shafts 10 with vitiligo...
Background Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor in adults. It characterized by its extremely poor prognosis despite available treatment strategies. Immune evasion described via PD-L1/ PD-1 interaction. Programmed death ligand 1 (PD-L1) a cell surface expressed on of several tumors including GBM receptor (Programmed deasth-1). Other melanoma non-small lung cancer, showed promising results using PD-L1/PD1 blockade strategies where PD-L1 was as...